• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴性症状的纵向轨迹与大脑皮质厚度变化:10 年随访研究。

Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study.

机构信息

Mental Health Service, Hospital Universitario Virgen del Rocío, Seville, Spain; Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM), Madrid, Spain; and Instituto de Biomedicina de Sevilla (IBiS)/HUVR/CSIC/Universidad de Sevilla, Seville, Spain.

Mental Health Service, Hospital Universitario Virgen del Rocío, Seville, Spain; Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM), Madrid, Spain; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain; and Department of Psychiatry, Universidad de Sevilla, Seville, Spain.

出版信息

Br J Psychiatry. 2023 Jul;223(1):309-318. doi: 10.1192/bjp.2022.192.

DOI:10.1192/bjp.2022.192
PMID:36805840
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10331319/
Abstract

BACKGROUND

Understanding the evolution of negative symptoms in first-episode psychosis (FEP) requires long-term longitudinal study designs that capture the progression of this condition and the associated brain changes.

AIMS

To explore the factors underlying negative symptoms and their association with long-term abnormal brain trajectories.

METHOD

We followed up 357 people with FEP over a 10-year period. Factor analyses were conducted to explore negative symptom dimensionality. Latent growth mixture modelling (LGMM) was used to identify the latent classes. Analysis of variance (ANOVA) was conducted to investigate developmental trajectories of cortical thickness. Finally, the resulting ANOVA maps were correlated with a wide set of regional molecular profiles derived from public databases.

RESULTS

Three trajectories (stable, decreasing and increasing) were found in each of the three factors (expressivity, experiential and attention) identified by the factor analyses. Patients with an increasing trajectory in the expressivity factor showed cortical thinning in caudal middle frontal, pars triangularis, rostral middle frontal and superior frontal regions from the third to the tenth year after the onset of the psychotic disorder. The -statistic map of cortical thickness expressivity differences was associated with a receptor density map derived from positron emission tomography data.

CONCLUSIONS

Stable and decreasing were the most common trajectories. Additionally, cortical thickness abnormalities found at relatively late stages of FEP onset could be exploited as a biomarker of poor symptom outcome in the expressivity dimension. Finally, the brain areas with less density of receptors spatially overlap areas that discriminate the trajectories of the expressivity dimension.

摘要

背景

了解首发精神病(FEP)患者阴性症状的演变需要长期的纵向研究设计,以捕捉该疾病的进展及其相关的大脑变化。

目的

探讨阴性症状的潜在因素及其与长期异常大脑轨迹的关系。

方法

我们对 357 名 FEP 患者进行了为期 10 年的随访。进行因子分析以探索阴性症状的维度。采用潜在增长混合模型(LGMM)来识别潜在的类别。方差分析(ANOVA)用于研究皮质厚度的发展轨迹。最后,将所得的 ANOVA 图谱与从公共数据库中获得的广泛的区域分子图谱进行相关分析。

结果

在因子分析中确定的三个因子(表达性、体验性和注意力)中,每个因子都发现了三种轨迹(稳定、下降和增加)。在表达性因子中呈增加轨迹的患者,从精神病发病后的第三年到第十年,在尾侧中额、三角部、额前和额上回出现皮质变薄。皮质厚度表达差异的 -统计量图谱与正电子发射断层扫描数据衍生的受体密度图谱相关。

结论

稳定和下降是最常见的轨迹。此外,在 FEP 发病相对较晚阶段发现的皮质厚度异常可作为表达维度不良症状结局的生物标志物。最后,受体密度较低的脑区与区分表达维度轨迹的脑区空间重叠。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/10331319/1df3d42a3d5f/S0007125022001921_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/10331319/399552dd8a95/S0007125022001921_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/10331319/3bbc7d2a06ca/S0007125022001921_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/10331319/337cd6fc5605/S0007125022001921_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/10331319/1df3d42a3d5f/S0007125022001921_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/10331319/399552dd8a95/S0007125022001921_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/10331319/3bbc7d2a06ca/S0007125022001921_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/10331319/337cd6fc5605/S0007125022001921_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142a/10331319/1df3d42a3d5f/S0007125022001921_fig4.jpg

相似文献

1
Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study.阴性症状的纵向轨迹与大脑皮质厚度变化:10 年随访研究。
Br J Psychiatry. 2023 Jul;223(1):309-318. doi: 10.1192/bjp.2022.192.
2
Intersection of verbal memory and expressivity on cortical contrast and thickness in first episode psychosis.首发精神病患者皮质对比和厚度的言语记忆和表达力的交集。
Psychol Med. 2020 Aug;50(11):1923-1936. doi: 10.1017/S0033291719002071. Epub 2019 Aug 28.
3
Longitudinal changes in cortical thickness in autism and typical development.自闭症与典型发育过程中的皮质厚度的纵向变化。
Brain. 2014 Jun;137(Pt 6):1799-812. doi: 10.1093/brain/awu083. Epub 2014 Apr 22.
4
Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.22q11.2 缺失综合征患者皮质厚度的纵向轨迹作为精神病生物标志物。
Schizophr Res. 2017 Oct;188:35-41. doi: 10.1016/j.schres.2016.11.041. Epub 2016 Dec 15.
5
Longitudinal trajectory of clinical insight and covariation with cortical thickness in first-episode psychosis.首发精神病患者临床洞察力的纵向轨迹及其与皮质厚度的共变关系
J Psychiatr Res. 2017 Mar;86:46-54. doi: 10.1016/j.jpsychires.2016.11.008. Epub 2016 Nov 19.
6
Early-Stage Negative Symptom Trajectories and Relationships With 13-Year Outcomes in First-Episode Nonaffective Psychosis.首发非情感性精神病早期负性症状轨迹及其与 13 年结局的关系。
Schizophr Bull. 2019 Apr 25;45(3):610-619. doi: 10.1093/schbul/sby115.
7
Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies.在 OPTiMiSE 和 GAP 研究中,与首次发作精神病的负性症状严重程度相关的皮质异质性与从规范模型中得出的极端偏差。
Transl Psychiatry. 2023 Dec 2;13(1):373. doi: 10.1038/s41398-023-02661-6.
8
Pre-onset sub-threshold psychotic symptoms and cortical organization in the first episode of psychosis.首发精神病前阈下精神病症状与皮质结构。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jun 8;100:109879. doi: 10.1016/j.pnpbp.2020.109879. Epub 2020 Jan 28.
9
The course of negative symptom in first episode psychosis and the relationship with social recovery.首发精神病阴性症状的病程及其与社会康复的关系。
Schizophr Res. 2016 Jul;174(1-3):165-171. doi: 10.1016/j.schres.2016.04.017. Epub 2016 Apr 28.
10
No progressive brain changes during a 1-year follow-up of patients with first-episode psychosis.首发精神病患者1年随访期间无进行性脑改变。
Psychol Med. 2016 Feb;46(3):589-98. doi: 10.1017/S003329171500210X. Epub 2015 Nov 3.

引用本文的文献

1
Using normative models pre-trained on cross-sectional data to evaluate intra-individual longitudinal changes in neuroimaging data.使用在横断面数据上预训练的规范模型来评估神经影像数据中的个体内纵向变化。
Elife. 2025 Mar 12;13:RP95823. doi: 10.7554/eLife.95823.
2
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Levels.精神分裂症早期和确诊期的抑郁及阴性症状:整合脑结构改变、认知表现及血浆白细胞介素6水平
Biol Psychiatry Glob Open Sci. 2024 Dec 2;5(2):100429. doi: 10.1016/j.bpsgos.2024.100429. eCollection 2025 Mar.
3

本文引用的文献

1
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex.将神经递质系统映射到人类新皮层的结构和功能组织上。
Nat Neurosci. 2022 Nov;25(11):1569-1581. doi: 10.1038/s41593-022-01186-3. Epub 2022 Oct 27.
2
Transcriptomic and connectomic correlates of differential spatial patterning among gliomas.转录组学和连接组学与胶质瘤之间不同空间模式的相关性。
Brain. 2023 Mar 1;146(3):1200-1211. doi: 10.1093/brain/awac378.
3
Local molecular and global connectomic contributions to cross-disorder cortical abnormalities.
Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel.
鲁拉西酮治疗首发精神病的疗效:患者表型、剂量及专家小组建议
Neurol Ther. 2025 Feb;14(1):85-98. doi: 10.1007/s40120-024-00700-y. Epub 2025 Jan 6.
4
Pharmacological Treatments of Negative Symptoms in Schizophrenia-An Update.精神分裂症阴性症状的药物治疗——最新进展
J Clin Med. 2024 Sep 23;13(18):5637. doi: 10.3390/jcm13185637.
5
Comparison of Negative Symptom Network Structures Between Patients With Early and Chronic Schizophrenia: A Network and Exploratory Graph Analysis.早期与慢性精神分裂症患者阴性症状网络结构的比较:网络与探索性图分析
Schizophr Bull. 2025 May 8;51(3):672-683. doi: 10.1093/schbul/sbae135.
6
A 10-Year Longitudinal Study of Brain Cortical Thickness in People with First-Episode Psychosis Using Normative Models.一项使用规范模型对首发精神病患者脑皮质厚度进行的10年纵向研究。
Schizophr Bull. 2024 Dec 20;51(1):95-107. doi: 10.1093/schbul/sbae107.
7
20-year trajectories of positive and negative symptoms after the first psychotic episode in patients with schizophrenia spectrum disorder: results from the OPUS study.精神分裂症谱系障碍患者首次精神病发作后20年的阳性和阴性症状轨迹:OPUS研究结果
World Psychiatry. 2023 Oct;22(3):424-432. doi: 10.1002/wps.21121.
局部分子和整体连接组学对跨疾病皮质异常的贡献。
Nat Commun. 2022 Aug 10;13(1):4682. doi: 10.1038/s41467-022-32420-y.
4
Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale.使用简明阴性症状量表定义精神分裂症的阴性症状缓解。
Rev Psiquiatr Salud Ment (Engl Ed). 2022 Jan-Mar;15(1):3-13. doi: 10.1016/j.rpsmen.2022.01.007.
5
Negative Symptoms: A Brief Story and Advances in Spain.阴性症状:西班牙的一个简短故事及进展
Rev Psiquiatr Salud Ment (Engl Ed). 2022 Jan-Mar;15(1):1-2. doi: 10.1016/j.rpsmen.2022.02.001.
6
Pars Triangularis Volume Asymmetry and Schneiderian First Rank Symptoms in Antipsychotic-naïve Schizophrenia.初发未使用抗精神病药物的精神分裂症患者的三角区体积不对称与施奈德首级症状
Clin Psychopharmacol Neurosci. 2021 Aug 31;19(3):507-513. doi: 10.9758/cpn.2021.19.3.507.
7
Mapping gene transcription and neurocognition across human neocortex.绘制人类新皮层中的基因转录图谱与神经认知图谱。
Nat Hum Behav. 2021 Sep;5(9):1240-1250. doi: 10.1038/s41562-021-01082-z. Epub 2021 Mar 25.
8
EPA guidance on assessment of negative symptoms in schizophrenia.美国环保署关于精神分裂症阴性症状评估的指南。
Eur Psychiatry. 2021 Feb 18;64(1):e23. doi: 10.1192/j.eurpsy.2021.11.
9
Brain changes associated with negative symptoms in clinical high risk for psychosis: A systematic review.精神病临床高危状态下与阴性症状相关的脑改变:一项系统综述。
Neurosci Biobehav Rev. 2020 Nov;118:367-383. doi: 10.1016/j.neubiorev.2020.07.041. Epub 2020 Aug 6.
10
Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand C-UCB-J.成人及青少年突触囊泡糖蛋白2A放射性配体C-UCB-J的生物分布与剂量测定
EJNMMI Res. 2020 Jul 14;10(1):83. doi: 10.1186/s13550-020-00670-w.